-
-
-
-
-
-
-
Amneal Pharmaceuticals to acquire Kashiv BioSciences in biosimilar deal
-
-
-
-
-
-
-
Amneal Reports Second Quarter 2025 Financial Results
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) Launches FOCINVEZ
-
-
-
-
-
-
-
Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California
-
-
-
-
-
-
-
Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
-
-
-
-
-
-
-
Amneal Pharmaceuticals (AMRX) to Move to Nasdaq
-
1,178,429 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

